Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Autor: Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W. Lin, Janet L. Stanford, Lisa F. Newcomb, Suzanne Kolb, Antonio Finelli, Neil E. Fleshner, Maria Komisarenko, James A. Eastham, Behfar Ehdaie, Nicole Benfante, Christopher J. Logothetis, Justin R. Gregg, Cherie A. Perez, Sergio Garza, Jeri Kim, Leonard S. Marks, Merdie Delfin, Danielle Barsa, Danny Vesprini, Laurence H. Klotz, Andrew Loblaw, Alexandre Mamedov, S. Larry Goldenberg, Celestia S. Higano, Maria Spillane, Eugenia Wu, H. Ballentine Carter, Christian P. Pavlovich, Mufaddal Mamawala, Tricia Landis, Peter R. Carroll, June M. Chan, Matthew R. Cooperberg, Janet E. Cowan, Todd M. Morgan, Javed Siddiqui, Rabia Martin, Eric A. Klein, Karen Brittain, Paige Gotwald, Daniel A. Barocas, Jeremiah R. Dallmer, Jennifer B. Gordetsky, Pam Steele, Shilajit D. Kundu, Jazmine Stockdale, Monique J. Roobol, Lionne D.F. Venderbos, Martin G. Sanda, Rebecca Arnold, Dattatraya Patil, Christopher P. Evans, Marc A. Dall’Era, Anjali Vij, Anthony J. Costello, Ken Chow, Niall M. Corcoran, Soroush Rais-Bahrami, Courtney Phares, Douglas S. Scherr, Thomas Flynn, R. Jeffrey Karnes, Michael Koch, Courtney Rose Dhondt, Joel B. Nelson, Dawn McBride, Michael S. Cookson, Kelly L. Stratton, Stephen Farriester, Erin Hemken, Walter M. Stadler, Tuula Pera, Deimante Banionyte, Fernando J. Bianco, Jr., Isabel H. Lopez, Stacy Loeb, Samir S. Taneja, Nataliya Byrne, Christopher L. Amling, Ann Martinez, Luc Boileau, Franklin D. Gaylis, Jacqueline Petkewicz, Nicholas Kirwen, Brian T. Helfand, Jianfeng Xu, Denise M. Scholtens, William J. Catalona, John S. Witte

Publikováno v: HGG Advances, Vol 3, Iss 1, Pp 100070- (2022)

Summary: Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for PC, many men on AS eventually convert to active

Externí odkaz: https://doaj.org/article/dd671a3166f5492e9f3db2429cd59265

MRI/US fusion guided prostate cryotherapy in the office setting under local anesthesia

Autor: Fernando J. Bianco, Jr, Eusebio Luna, Alberto Lopez-Prieto, Juan I. Martinez-Salamanca, Edward L. Gheiler, Ariel M. Kaufman, Farshad Shafizadeh, Michael J. Zachareas, Luanda Y. Perez, Gloria Egui-Benatuil

Publikováno v: Urology Video Journal, Vol 8, Iss , Pp 100065- (2020)

Externí odkaz: https://doaj.org/article/561adeff3ba44f098244a8237a58d351

Super active surveillance for low-risk prostate cancer | Opinion: Yes

Autor: Leonardo O. Reis, Danilo L. Andrade, Fernando J. Bianco Jr.

Publikováno v: International Brazilian Journal of Urology, Vol 45, Iss 2, Pp 210-214

Externí odkaz: https://doaj.org/article/3847a434948747a5a15707fd3f5bf7fc

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

Autor: Juan A Ramos, Fernando J Bianco

Publikováno v: Indian Journal of Urology, Vol 28, Iss 1, Pp 9-14 (2012)

Prostate cancer is a global public health problem, and it is the most common cancer in American men and the second cause for cancer-related death. Experimental evidence shows that prostate tissue possesses cannabinoid receptors and their stimulation

Externí odkaz: https://doaj.org/article/fef5f1086e41464aa41a4a3dbfd386fb

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Autor: Marc A. Dall'Era, R. Jeffrey Karnes, Jacqueline Petkewicz, Michael S. Cookson, Eric A. Klein, Soroush Rais-Bahrami, Jeremiah R. Dallmer, Kelly L. Stratton, Phillip R. Cooper, Denise M. Scholtens, James A. Eastham, Janet L. Stanford, Rebecca S. Arnold, Peter R. Carroll, S. Larry Goldenberg, Monique J. Roobol, Niall M. Corcoran, Lisa F. Newcomb, Stephen Farriester, Antonio Finelli, Nicola Lancki, Nataliya Byrne, Thomas Flynn, Neil E. Fleshner, Anthony J. Costello, Christian P. Pavlovich, Rabia Martin, Matthew R. Cooperberg, John S. Witte, Ann Martinez, Leonard S. Marks, Lauren Folgosa Cooley, Mufaddal Mamawala, Martin G. Sanda, Lionne D.F. Venderbos, Joel B. Nelson, Maria Spillane, Nicholas Kirwen, Sergio Garza, Erin Hemken, William J. Catalona, Shilajit Kundu, Paige Gotwald, Courtney Phares, Fernando J. Bianco, Tuula Pera, Justin R. Gregg, Todd M. Morgan, June M. Chan, Dawn McBride, Courtney Rose Dhondt, Andrew Loblaw, Jeri Kim, Maria Komisarenko, Brian T. Helfand, Deimante Banionyte, Karen Brittain, Janet E. Cowan, Christopher P. Evans, Walter M. Stadler, Danny Vesprini, Linda Kachuri, Franklin Gaylis, Danielle Barsa, Yu Jiang, Javed Siddiqui, Cherie Perez, Isabel H. Lopez, Daniel W. Lin, Travis J. Meyers, Alexandre Mamedov, Tricia Landis, Ken Chow, Luc Boileau, Douglas S. Scherr, Christopher J. Logothetis, Celestia S. Higano, Merdie Delfin, Stacy Loeb, Adaeze A. Emeka, Anjali Vij, Jennifer B. Gordetsky, Irene Helenowski, Laurence Klotz, Pam Steele, Suzanne Kolb, Eugenia Wu, Christopher L. Amling, DA Barocas, Samir S. Taneja, Michael O. Koch, Dattatraya Patil, Behfar Ehdaie, Jazmine Stockdale, Nicole Benfante, H. Ballentine Carter, Jianfeng Xu

Publikováno v: Human Genetics and Genomics Advances
HGG Advances, Vol 3, Iss 1, Pp 100070-(2022)
Human Genetics and Genomics Advances, 3(1):100070. Cell Press
HGG advances, vol 3, iss 1

Summary Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for PC, many men on AS eventually convert to active

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef05bc911ab1518924ae422daa169dd1
http://europepmc.org/articles/PMC8725988